Biomarkers along the continuum of care in lung cancer

Blood-based biomarkers are valuable diagnostic tools for the management of lung cancer patients. They support not only differential diagnosis and histological subtyping, but are also applied for estimation of prognosis, stratification for specific therapies, monitoring of therapy response, surveilla...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Scandinavian journal of clinical & laboratory investigation. Supplement Ročník 76; číslo 45; s. S40 - S45
Hlavní autor:	Holdenrieder, Stefan
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Norway Taylor & Francis 13.07.2016
Témata:	Antigens, Neoplasm - blood Antigens, Neoplasm - genetics Antineoplastic Agents - therapeutic use Biomarker Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Carcinoembryonic Antigen - blood Carcinoembryonic Antigen - genetics diagnosis DNA, Neoplasm - blood DNA, Neoplasm - genetics Early Diagnosis Gene Expression Regulation, Neoplastic Humans Keratin-19 - blood Keratin-19 - genetics liquid profiling lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Peptide Fragments - blood Peptide Fragments - genetics personalized medicine Phosphopyruvate Hydratase - blood Phosphopyruvate Hydratase - genetics Prognosis Recombinant Proteins - blood Recombinant Proteins - genetics Serpins - blood Serpins - genetics serum Transcriptome Treatment Outcome lung cancer liquid profiling diagnosis Biomarker serum personalized medicine
ISSN:	0036-5513, 2166-1030, 1502-7686, 2166-1030
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!